Annual report pursuant to Section 13 and 15(d)

STOCK-BASED COMPENSATION (Details Narrative)

v3.7.0.1
STOCK-BASED COMPENSATION (Details Narrative) - USD ($)
 12 Months Ended
Oct. 21, 2015
Feb. 28, 2017
Feb. 29, 2016
Jun. 29, 2016
Sep. 30, 2015
Common shares par value (in dollars per share)   $ 0.01 $ 0.01    
Accrued expenses   $ 417,357 $ 499,406    
Independent Directors ( Dr. Mark Baker, Mr. Mark Pastreich, Mr. Arthur Radin and Mr. Cyril Narishkin) [Member]          
Description of payment terms

Paid quarterly half in cash and half in common stock.

        
Annually compensation paid per director $ 25,000        
Dr. Ma. [Member]          
Issuance of common stock   $ 10,870      
2015 Stock Option Plan [Member]          
Number of shares authorized       4,000,000 2,000,000
Number of common shares awarded   500,000 1,155,000    
Common shares par value (in dollars per share)         $ 0.01
Weighted average grant date fair value of stock options   $ 0.19 $ 0.21    
Allocated stock-based compensation expense   $ 115,828 $ 50,413    
Weighted-average grant-date fair value options granted   122,656 219,116    
Total intrinsic value of options exercised   0 0    
Total unrecognized compensation cost   $ 100,000      
Weighted-average period (in years)   17 months      
Total fair value of shares vested   $ 98,432 $ 0    
2015 Stock Option Plan [Member] | Key Employees [Member]          
Number of common shares awarded   1,345,000